Better outcome measures needed for clinical trials for Fragile X Syndrome
Monday, June 12, 2017 - 12:31
in Health & Medicine
A group of researchers from several institutions in the USA reports that its review of 22 clinical trials of fragile X syndrome (FXS) suggests the need for a wider use of newer and improved treatment outcome measurement tools for this and other several neurodevelopmental disorders. FXS is the most common inherited form of intellectual disability and the most common form of autism associated with a single gene mutation.